Kardium is expanding to the US with a special tech device to target atrial fibrillation. The expansion may be related to a significant milestone, possibly involving regulatory approval, although details of the approval are unclear. Additionally, there are reports of other companies, such as Abbott, making moves in the electrophysiology market, potentially through acquisitions.